VARIANT BIO: COMMERCIAL TERMS INCLUDE UPFRONT PAYMENT, ADDITIONAL NEAR-TERM R&D FUNDING UP TO $50 MLN, PLUS POTENTIAL OPTION, MILESTONE PAYMENTS

Reuters · 01/07 12:03

Please log in to view news